- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07606157
Effects of Kinesiotaping in Osteoarthritis (Taping)
Effects of Adding Kinesiotaping to Conventional Physiotherapy on Pain, Function, and Kinesiophobia in Knee Osteoarthritis: A Randomized Controlled Trial
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Studie Overzicht
Gedetailleerde beschrijving
Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.
This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.
A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Nazli Assoc. Prof. Nazli Cigercioglu, Assoc. Prof.
- Telefoonnummer: +90 541 290 32 93
- E-mail: nazlicigercioglu@gmail.com
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Diagnosis of unilateral grade 2 knee osteoarthritis,
- Age between 40 and 65 years,
- Ability to understand and comply with assessments and interventions,
- Independent ambulation without assistive devices,
- No participation in a physiotherapy program for knee-related complaints within the previous year
Exclusion Criteria:
- History of lower extremity surgery or trauma,
- Presence of neurological or orthopedic conditions affecting gait or physical function,
- Allergic reaction to kinesiotape,
- Inability to walk independently.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Sequentiële toewijzing
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Kinesiotaping
|
Kinesiotaping
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Kinesiophobia
Tijdsspanne: 4 weeks
|
Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ).
The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement.
The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.
|
4 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Pain intensity
Tijdsspanne: 4 weeks
|
Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from "no pain" (0) to "worst imaginable pain" .
Participants will be asked to indicate the intensity of their knee pain during activity, and the marked distance will be measured in centimeters
|
4 weeks
|
|
Functional status
Tijdsspanne: 4 weeks
|
Functional status will be assessed using performance-based tests.
The 30-Second Sit-to-Stand Test will be used to evaluate lower extremity muscle strength and endurance.
Participants will be instructed to stand up and sit down as many times as possible within 30 seconds, and the total number of repetitions will be recorded .
|
4 weeks
|
|
Functional mobility
Tijdsspanne: 4 weeks
|
The 12-Step Stair Climb Test will be used to assess functional mobility and lower limb performance.
Participants will be asked to ascend and descend a 12-step staircase as quickly and safely as possible, and the total time taken to complete the task will be recorded in seconds .
|
4 weeks
|
|
Dynamic balance
Tijdsspanne: 4 weeks
|
Dynamic balance will be evaluated using the Functional Reach Test.
Participants will be instructed to stand upright and reach forward as far as possible without losing balance or taking a step.
The maximum distance reached will be measured in centimeters .
|
4 weeks
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Cigercioglu, Hacettepe University
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- OA_RCS_2026
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .